An open trial of pentoxifylline in schamberg's disease.
Fifteen patients with Schamberg's disease were enrolled in the study. Each patient was given 400mg of pentoxifylline once a day for 8 weeks. Skin biopsy was done in 6 patients to document the disease. Pretreatment and post treatment evaluation were made. There was no objective improvement in any of the patients though 4 reported subjective improvement in their pigmentation.
Kumrah
L
L
Department of Dermatology, Christian Medical College and Hospital, Vellore, Tamilnadu, India.
George
R
R
George
S
S